The context-dependent role of the complement system in cancer has the potential to provide novel prognostic biomarkers to inform treatment decisions for cancer patients
Portuguese researchers, INESC TEC, and the IMP Diagnostics Molecular & Anatomic Pathology laboratory, focus on improving the prototype that uses AI as a complementary tool when diagnosing colon and rectal biopsies
Complete range of standard solutions and rapid staining kits. Cytochemical method support. Ready-to-use products. In Vitro Diagnostic Medical Devices (IVD) registered and Community of Europe (CE) certified. Brilliant images and contrasts. Stable results with pH-buffered solutions. Panoptic methods Merck Millipore offers all standard staining solutions, such as Giemsa, Leishman, Wright or May-Grünwald,…
Company also receives new FDA emergency use authorizations for use of self-collection molecular diagnostic kit on the Hologic and Roche platforms
The Inhibin A enzyme linked immunosorbent assay (ELISA) kit provides materials for the quantitative measurement of dimeric inhibin A in human serum and plasma. It is intended for in vitro diagnostic use as an aid in the diagnosis and monitoring of various hormonal reproductive disorders.
VENTANA MMR RxDx Panel is the first immunohistochemistry predictive test in endometrial cancer for treatment with the anti-PD1 immunotherapy JEMPERLI
CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO
The VENTANA ROS1 (SP384) rabbit monoclonal primary antibody is designed to effectively identify elevated ROS1 protein expression
New and unique opportunity to advance cancer treatment
Expected to be first commercially-available blood-based invitro diagnostic for patients being assessed for Alzheimer’s disease in the US
Bruker and RECIPE are pioneering the high-throughput ‘chrom-free’ ClinDART triple-quad MS platform for robust and cost-effective therapeutic drug monitoring assays
Hitachi and the Centre Leon Berard Cancer Center to launch research into diagnosis and treatment
Data to be presented as a late-breaking abstract at the 2025 European Society for Medical Oncology (ESMO) Breast Cancer Congress
T8 ISOTHERMAL DIAGNOSTICS INSTRUMENT. The Axxin T8 Isothermal instrument is a highly flexible bench-top and field deployable platform designed to provide quantitative and qualitative results for molecular diagnostic isothermal assay applications.
Experts discuss the game-changing potential of novel host response-based diagnostics to combat the global challenge of antimicrobial resistance (AMR)
Discover how a smartphone-based diagnostic platform is democratizing point-of-care testing away from the clinic into a home testing setting
